High-dose intravenous methylprednisolone may offer unique therapeutic benefits, potentially reducing long-term glucocorticoid side effects. Further research is needed to confirm its efficacy in dermatologic conditions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: